Fiona A Pearce1, Peter C Lanyon2, Matthew J Grainge3, Reena Shaunak4, Alfred Mahr5, Richard B Hubbard3, Richard A Watts6. 1. Division of Epidemiology and Public Health, University of Nottingham, Department of Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, fiona.pearce@nottingham.ac.uk. 2. Department of Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham. 3. Division of Epidemiology and Public Health, University of Nottingham. 4. Department of Rheumatology, Derby Teaching Hospitals NHS Trust, Derby, UK. 5. Department of Internal Medicine, Hospital Saint-Louis, Paris, France. 6. Department of Rheumatology, Ipswich Hospital, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK.
Abstract
OBJECTIVES: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group. METHODS: We identified incident cases of ANCA-associated vasculitis between March 2007 and June 2013 in the Nottingham-Derby urban area from medical records using multiple sources. We derived the denominator population from the 2011 census, and we calculated incidence rate ratios using Poisson regression. RESULTS: Overall, we identified 107 cases of ANCA-associated vasculitis, giving an incidence of 23.1 per million person-years (95% CI: 18.9, 27.9). The incidence among the white population was 25.8 per million person-years (95% CI: 21.0, 31.3) and among the black and minority ethnic (BME) population 8.4 per million person-years (95% CI: 3.1, 18.3). After adjustment for age and sex, the difference between ethnic groups was not statistically significant (incidence rate ratio 0.7, 95% CI: 0.3, 1.5, P = 0.3). CONCLUSION: Overall, the incidence of ANCA-associated vasculitis was similar to other epidemiological studies. Crude incidence rates were lower in the BME than in the white population, but this was partly explained by the older age profile among the white compared with BME population.
OBJECTIVES: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group. METHODS: We identified incident cases of ANCA-associated vasculitis between March 2007 and June 2013 in the Nottingham-Derby urban area from medical records using multiple sources. We derived the denominator population from the 2011 census, and we calculated incidence rate ratios using Poisson regression. RESULTS: Overall, we identified 107 cases of ANCA-associated vasculitis, giving an incidence of 23.1 per million person-years (95% CI: 18.9, 27.9). The incidence among the white population was 25.8 per million person-years (95% CI: 21.0, 31.3) and among the black and minority ethnic (BME) population 8.4 per million person-years (95% CI: 3.1, 18.3). After adjustment for age and sex, the difference between ethnic groups was not statistically significant (incidence rate ratio 0.7, 95% CI: 0.3, 1.5, P = 0.3). CONCLUSION: Overall, the incidence of ANCA-associated vasculitis was similar to other epidemiological studies. Crude incidence rates were lower in the BME than in the white population, but this was partly explained by the older age profile among the white compared with BME population.
Authors: Sirada Panupattanapong; Dustin L Stwalley; Andrew J White; Margaret A Olsen; Anthony R French; Mary E Hartman Journal: Arthritis Rheumatol Date: 2018-12 Impact factor: 10.995
Authors: Fiona A Pearce; Catherine McGrath; Ravinder Sandhu; Jon Packham; Richard A Watts; Benjamin Rhodes; Reem Al-Jayyousi; Lorraine Harper; Karen Obrenovic; Peter Lanyon Journal: Rheumatol Adv Pract Date: 2018-07-31
Authors: Jonathan La-Crette; Jeremy Royle; Peter C Lanyon; Alastair Ferraro; Amanda Butler; Fiona A Pearce Journal: Clin Rheumatol Date: 2017-12-15 Impact factor: 2.980
Authors: Christof Iking-Konert; Pia Wallmeier; Sabrina Arnold; Sabine Adler; Kirsten de Groot; Bernhard Hellmich; Bimba F Hoyer; Konstanze Holl-Ulrich; Gabriele Ihorst; Margit Kaufmann; Ina Kötter; Ulf Müller-Ladner; T Magnus; Jürgen Rech; Fabian Schubach; Hendrik Schulze-Koops; Nils Venhoff; Thorsten Wiech; Peter Villiger; Peter Lamprecht Journal: BMC Rheumatol Date: 2021-07-31